Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 376

WBA moves into VillageMD with $250m

VillageMD is set to receive a total of $1bn in equity and convertible debt financing from Walgreens Boots Alliance over the next three years, giving the corporate a 30% stake.

Jul 9, 2020

Perfect Day reveals $300m series C

Continental Grain-backed Perfect Day has raised a further $160m for a round that increased the vegan dairy protein developer's overall funding to more than $360m.

Jul 9, 2020

Suse corrals Rancher Labs

Tesltra Ventures is exiting Kubernetes management platform developer Rancher in an acquisition reportedly sized at between $600m and $700m.

Jul 9, 2020

VelosBio sells investors on $137m series B

The cancer therapy developer boosted its overall funding to more than $200m in a round that included series A backer Takeda Ventures.

Jul 9, 2020

OwnBackup stacks up $50m

Salesforce Ventures returned for a round that pushed the data backup technology developer's total funding past $100m and doubled its valuation.

Jul 9, 2020

Corporates help energise Natron's $35m series D

ABB Technology Ventures co-led a round including Chevron that increased sodium-ion battery developer Natron's lifetime funding to more than $70m.

Jul 9, 2020

Apiture reaches Pinnacle in $20m round

The digital banking tool provider, formed by Live Oak Bank and First Data, has pulled in funding from investors including Pinnacle Bank.

Jul 9, 2020

Sayari strengthens series B round

The financial mapping software provider has added $2.5m to the SAP-backed first tranche it closed in January, taking the round to $11.5m.

Jul 8, 2020

Ucommune opens its doors to reverse merger

The co-working space provider, which counts a slew of corporates among its investors, will list on Nasdaq by merging with a SPAC in a deal jointly valuing them at $769m.

Jul 8, 2020

Vor gets more in $110m series B

Stem-cell cancer treatment developer Vor Biopharma has collected more capital from investors including existing backers Johnson & Johnson and PureTech Health.

Jul 8, 2020
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here